Anti-GSK3 (alpha + beta) (phospho Y279 + Y216) 抗体 (ab52188)

ab52188 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab52188 は 3 報の論文で使用されています。

  • Atkinson JM  et al. Activating the Wnt/ß-Catenin Pathway for the Treatment of Melanoma--Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3. PLoS One 10:e0125028 (2015). WB ; Human . PubMed: 25915038
  • Darrington RS  et al. Distinct expression and activity of GSK-3a and GSK-3ß in prostate cancer. Int J Cancer 131:E872-83 (2012). PubMed: 22539113
  • Campa VM & Kypta RM Issues associated with the use of phosphospecific antibodies to localise active and inactive pools of GSK-3 in cells. Biol Direct 6:4 (2011). WB, ICC/IF ; Human . PubMed: 21261990

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"